Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-755 in Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
NCT05714969Phase 2Completed
- Sponsor
- Takeda
- Start
- Jul 2023
- Primary completion
- Apr 2026
- Modality
- Replacement Enzymes
- Countries
- 6
01
Overview
A Phase 2 trial of Apadamtase alfa in thrombotic thrombocytopenic purpura (TTP), sponsored by Takeda. Started Jul 2023; status: completed.
02
Drugs
Apadamtase alfa
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on NCT05714969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05714969.